AI |
Artificial intelligence |
ACS |
Acute coronary syndrome |
AHA |
American Heart Association |
AMI |
Acute myocardial infarction |
AMR |
Antimicrobial resistance |
CAD |
Coronary artery disease |
CAMA |
Coronary artery mycotic aneurysm |
CT |
Computed tomography |
DES |
Drug-eluting stents |
EE |
Embolic events |
ESC |
European Society of Cardiology |
IE |
Infective endocarditis |
GD |
Graves’ disease |
HF |
Heart failure |
IBD |
Inflammatory bowel disease |
JACC |
Journal of the American College of Cardiology |
IVDA |
Intravenous drug abusers |
LAD |
Anterior descending artery |
LCX |
Left coronary circumflex artery |
LMCA |
Left main coronary artery |
LSE |
Libman–Sacks endocarditis |
MIC |
Minimum inhibitory concentration |
MRI |
Cardiac magnetic resonance |
MRSA |
Methicillin-resistant Staphylococcus aureus |
MS |
Multiple sclerosis |
MSSA |
Methicillin-susceptible Staphylococcus aureus |
NSTEMI |
NON-ST elevation myocardial infarction |
NVE |
Native valve endocarditis |
PREMs |
Patient-reported Experience Measures |
PROMs |
Patient-reported Outcome Measures |
PVE |
Prosthetic valve endocarditis |
RA |
Rheumatoid arthritis |
RCA |
Right coronary artery |
SLE |
Systemic lupus erythematosus |
STEMI |
ST elevation myocardial infarction |
TDM |
Therapeutic drug monitoring |
TOE |
Transesophageal cardiac ultrasound |
TTE |
Transthoracic cardiac ultrasound |
T1D |
Type 1 diabetes |
T2D |
Type 2 diabetes |
UI |
Uncontrolled infection |
WHO |
World Health Organization |